Bank of Baroda stock rises on Rs 15,000 crore bond issue plan
Post Content
Post Content
Post Content Post Views: 114
Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in mid-2024. Post Views: 126
Post Content Post Views: 140
Post Content Post Views: 125
Post Content Post Views: 126
Post Content Post Views: 131